Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of IA vs IV 68Ga-PSMA-11 in Prostate Cancer
NCT04976257Phase 1Completed
- Start
- Oct 2021
- Primary completion
- Mar 2023
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of gallium ga-68 gozetotide in prostate adenocarcinoma. Primary endpoint: Maximum Standardized Uptake Value. Started Oct 2021; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT04976257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976257.